Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Cash from Operations (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Cash from Operations for 15 consecutive years, with 1961000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Operations fell 106.64% to 1961000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 31524000.0, a 61.19% decrease, with the full-year FY2024 number at 60992000.0, down 13.66% from a year prior.
  • Cash from Operations was 1961000.0 for Q3 2025 at Usana Health Sciences, down from 12218000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 40463000.0 in Q4 2022 to a low of 1961000.0 in Q3 2025.
  • A 5-year average of 17039647.06 and a median of 15482000.0 in 2025 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: surged 362.91% in 2022, then crashed 106.64% in 2025.
  • Usana Health Sciences' Cash from Operations stood at 19659000.0 in 2021, then soared by 105.82% to 40463000.0 in 2022, then crashed by 35.69% to 26023000.0 in 2023, then plummeted by 77.77% to 5785000.0 in 2024, then tumbled by 133.9% to 1961000.0 in 2025.
  • Per Business Quant, the three most recent readings for USNA's Cash from Operations are 1961000.0 (Q3 2025), 12218000.0 (Q2 2025), and 15482000.0 (Q1 2025).